Quality by design with a focus on biosimilars
Pharmaceutical Technology
OCTOBER 28, 2022
They will need to conduct crossover studies in healthy individuals who will receive the brand name and the generic drug; the plasma concentration-time profile results will then be compared to see if the two are bioequivalent. coli, where small amounts of contaminants could cause significant toxicity.
Let's personalize your content